Neuroendocrine differentiation distinguishes basaloid variant of lung squamous cell carcinoma

Bibliographic Details
Title: Neuroendocrine differentiation distinguishes basaloid variant of lung squamous cell carcinoma
Authors: Kianoosh Keyhanian, William J. Phillips, Benjamin S. Yeung, Marcio Gomes, Bryan Lo, Harmanjatinder S. Sekhon
Source: Diagnostic Pathology, Vol 17, Iss 1, Pp 1-11 (2022)
Publisher Information: BMC, 2022.
Publication Year: 2022
Collection: LCC:Pathology
Subject Terms: Basaloid squamous cell carcinoma, Neuroendocrine differentiation, Gene expression, Immunohistochemistry, NOTCH, Pathology, RB1-214
More Details: Abstract Background Neuroendocrine (NE) differentiation is widely studied in non-small cell lung carcinomas (NSCLC) however, its significance remains unclear in basaloid squamous cell carcinomas (B-SqCC). This study aims to assess the extent of NE differentiation in B-SqCC and characterize the underlying molecular process. Methods This study evaluated resected B-SqCC, small cell lung cancer (SCLC) and poorly differentiated SqCC (PD-SqCC) from 2005 to 2020 at the Ottawa Hospital. Samples were subject to pathological review, immunohistochemistry (IHC) and survival analysis. Gene expression analysis was performed on B-SqCC samples exhibiting NE+ and NE- regions (paired samples) to identify differentially expressed genes (DEGs). These DEGs were subsequently validated in unpaired B-SqCC and TCGA samples. Results B-SqCC cases were more likely to exhibit nuclear molding, resetting and peripheral palisading than PD-SqCC. B-SqCC were also more likely to demonstrate NE differentiation compared to PD-SqCC (p = 0.006). Pure basaloid squamous cell carcinoma (PB-SqCC) experienced poorer disease-free survival (HR = 3.12, p = 0.043) adjusted for stage. Molecular characterization of paired B-SqCC samples demonstrated DEGs implicated in NOTCH signaling, SCLC and pulmonary neuroendocrine differentiation. Hierarchical clustering using discovered DEGs in unpaired B-SqCC samples distinguished tumors based on NE status (p = 0.048). Likewise, clustering The Cancer Genome Atlas (TCGA) samples with DEGs distinguished B-SqCC from SqCC samples (p = 0.0094). Conclusion This study provides IHC and molecular evidence of significant NE-differentiation in B-SqCC and demonstrates their aggressive clinical behavior. These findings suggest that B-SqCC are biologically distinct from SqCC and share characteristics with SCLC.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1746-1596
Relation: https://doaj.org/toc/1746-1596
DOI: 10.1186/s13000-022-01223-6
Access URL: https://doaj.org/article/20ca97d557be4832bf8cd30ef0d85a5f
Accession Number: edsdoj.20ca97d557be4832bf8cd30ef0d85a5f
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:17461596
DOI:10.1186/s13000-022-01223-6
Published in:Diagnostic Pathology
Language:English